Smith & Nephew/$SNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
- Ticker
- $SNN
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 17,000
- Headquarters
- Watford, United Kingdom
- Website
- www.smith-nephew.com
Smith & Nephew Metrics
BasicAdvanced
$12bn
40.57
$0.74
0.69
$0.75
3.13%
Price and volume
Market cap
$12bn
Beta
0.69
52-week high
$38.79
52-week low
$28.56
Average daily volume
1.7m
Dividend rate
$0.75
Financial strength
Current ratio
2.139
Quick ratio
1.109
Long term debt to equity
62.008
Total debt to equity
73.069
Dividend payout ratio (TTM)
52.44%
Interest coverage (TTM)
6.59%
Profitability
EBITDA (TTM)
1,382
Gross margin (TTM)
68.44%
Net profit margin (TTM)
10.08%
Operating margin (TTM)
14.22%
Effective tax rate (TTM)
20.33%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
5.16%
Return on equity (TTM)
11.85%
Valuation
Price to earnings (TTM)
40.571
Price to revenue (TTM)
4.051
Price to book
1.8
Price to tangible book (TTM)
11.15
Price to free cash flow (TTM)
29.849
Free cash flow yield (TTM)
3.35%
Free cash flow per share (TTM)
1
Dividend yield (TTM)
2.52%
Forward dividend yield
3.13%
Growth
Revenue change (TTM)
5.99%
Earnings per share change (TTM)
31.78%
3-year revenue growth (CAGR)
5.61%
10-year revenue growth (CAGR)
3.00%
3-year earnings per share growth (CAGR)
43.34%
10-year earnings per share growth (CAGR)
6.37%
3-year dividend per share growth (CAGR)
1.92%
10-year dividend per share growth (CAGR)
2.41%
What the Analysts think about Smith & Nephew
Analyst ratings (Buy, Hold, Sell) for Smith & Nephew stock.
Smith & Nephew Financial Performance
Revenues and expenses
Smith & Nephew Earnings Performance
Company profitability
Smith & Nephew News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.